1,032 results on '"Fehse, Boris"'
Search Results
302. TK.007: A Novel, Codon-Optimized HSVtk(A168H) Mutant for Suicide Gene Therapy
303. Highly efficient lentiviral transduction of phenotypically and genotypically characterized endothelial progenitor cells from adult peripheral blood
304. Mammary Epithelial Reconstitution with Gene-Modified Stem Cells Assigns Roles to Stat5 in Luminal Alveolar Cell Fate Decisions, Differentiation, Involution, and Mammary Tumor Formation
305. Induction Chemotherapy Followed Immediately by Busulfan-Based Reduced Conditioning and Allografting in Elderly Patients with Advanced MDS or sAML.
306. Related Vs Unrelated Donors After Auto-Allo Tandem Stem Cell Transplantation for Newly Diagnosed Patients with Multiple Myeloma.
307. Bone marrow mesenchymal stromal cells remain of recipient origin after allogeneic SCT and do not harbor the JAK2V617F mutation in patients with myelofibrosis
308. Post-transplant immunotherapy with donor-lymphocyte infusion and novel agents to upgrade partial into complete and molecular remission in allografted patients with multiple myeloma
309. JAK2-V617F–triggered preemptive and salvage adoptive immunotherapy with donor-lymphocyte infusion in patients with myelofibrosis after allogeneic stem cell transplantation
310. Reversal of P-glycoprotein–Mediated Multidrug Resistance by the Murine Double Minute 2 Antagonist Nutlin-3
311. Stem Cell Marking With Promotor-deprived Self-inactivating Retroviral Vectors Does Not Lead to Induced Clonal Imbalance
312. Quantitative monitoring of NPM1 mutations provides a valid minimal residual disease parameter following allogeneic stem cell transplantation
313. Chimerism Analyses in Stem Cell Recipients with Non Hodgkin Lymphoma
314. Resistance of mature T cells to oncogene transformation
315. Anti-thymocyte globulin overcomes the negative impact of HLA mismatching in transplantation from unrelated donors
316. Comparison of Two Doses of Antithymocyte Globulin in Patients Undergoing Matched Unrelated Donor Allogeneic Stem Cell Transplantation
317. Complement-dependent and complement-independent cytotoxicity of polyclonal antithymocyte globulins in chronic lymphocytic leukemia
318. Abnormal Expression of Only the CD34 Part of a Transgenic CD34/Herpes Simplex Virus-Thymidine Kinase Fusion Protein Is Associated with Ganciclovir Resistance
319. Clinical Application of a Retroviral Gene Transfer Protocol Based on Centrifugation-Mediated Vector Preloading
320. A Multicolor Panel of Novel Lentiviral “Gene Ontology” (LeGO) Vectors for Functional Gene Analysis
321. A comparative analysis of the leukemic potential of mature T cells versus T cell precursors
322. Differences in proportion and dynamics of recipient hematopoiesis following hematopoietic cell transplantation in CML and IMF
323. Overexpression of the p85α regulatory subunit of phosphatidylinositol 3-kinase inhibits GM-CSF-dependent colony formation of CD34+hematopoietic progenitor cells
324. Engraftment after Haematopoietic Stem Cell Transplantation: Which Predictors Are Most Important?.
325. High Efficiency Retro- and Lentiviral Transduction of Blood Endothelial Outgrowth Cells
326. Concordance of Assays Designed for the Quantitation of JAK2 1849G>T (V617F): A Multi-Centre Study.
327. NPM1 Mutations Are Valid Minimal Residual Disease Parameters Following Allogeneic Stem Cell Transplantation: A Study on 116 AML Patients.
328. Gene transfer of the Inositol 5-Phosphatase SHIP-1 inhibits proliferation of acute myeloid leukemia cells
329. Overexpression of the p85α subunit of PI3-kinase inhibits GM-CSF-dependent proliferation and colony formation of hematopoietic cells
330. CD34 Modulates the Trafficking Behavior of Hematopoietic CellsIn Vivo
331. Gentherapeutische Konzepte in der Onkologie.
332. mRNA transfection of a novel TAL effector nuclease (TALEN) facilitates efficient knockout of HIV co-receptor CCR5.
333. Retroviral vector insertion sites associated with dominant hematopoietic clones mark “stemness” pathways
334. Leukemogenic Cascade Induced by a Constitutively Active Neurotrophin Receptor, ΔTrkA.
335. A Comparative Analysis of the Leukaemic Potential of Mature T Cells Versus T Cell Precursors.
336. Highly Sensitive Real-Time PCR of V617F-JAK2-Mutation To Monitor Minimal Residual Disease and Guide Donor Lymphocte Infusion after Allogeneic Stem Cell Transplantation in Patients with Myelofibrosis.
337. Sensitive Balance of Suppressing and Activating Effects of Mesenchymal Stem Cells on T-cell Proliferation
338. Monitoring of the JAK2-V617F mutation by highly sensitive quantitative real-time PCR after allogeneic stem cell transplantation in patients with myelofibrosis
339. Kinetics of plasma-cell chimerism after allogeneic stem cell transplantation by highly sensitive real-time PCR based on sequence polymorphism and its value to quantify minimal residual disease in patients with multiple myeloma
340. Mutagenesis and Oncogenesis by Chromosomal Insertion of Gene Transfer Vectors
341. 769. Genes Encoding Receptors, Signal Transducers and Transcription Regulators Are Preferred Targets of Retroviral Vector Integration in T-Lymphocytes In Vitro and In Vivo
342. Antithymocyte globulin induces complement-dependent cell lysis and caspase-dependent apoptosis in myeloma cells
343. Kinetics of Plasma-Cell Chimerism after Allogeneic Stem Cell Transplantation by Real-Time PCR and Its Value To Quantify Minimal Residual Disease in Patients with Multiple Myeloma.
344. A ComParison of Retroviral Integration Sites in Donor T-Lymphocytes In Vivo and In Vitro.
345. Clonal Dominance of Hematopoietic Stem Cells Triggered by Retroviral Gene Marking
346. Antithymocyte Globulin Induces Ex Vivo and In Vivo Depletion of Myeloid and Plasmacytoid Dendritic Cells
347. Profiling Retroviral Integration Sites in Donor T-Lymphocytes for Suicide Gene Therapy.
348. More Than One Mutation Is Required for Leukemia Development Following Retroviral Vector-Mediated Gene Transfer.
349. Aldehyde Dehydrogenase Activity - the Better Marker for the Quality of Hematopoietic Stem Cell Transplants?!.
350. Low Dose Thalidomide and Donor Lymphocyte Infusion as Adoptive Immunotherapy after Allogeneic Stem Cell Transplantation in Patients with Multiple Myeloma.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.